Hassan Pervaiz

Suggest Changes
Learn More
Twenty-eight myelodysplastic syndromes (MDS) patients were treated with arsenic trioxide (ATO) and thalidomide. Seven patients responded including one complete hematologic and cytogenetic response(More)
  • 1